Preoperative treatment of anemia and outcomes in surgical Jehovah's Witness patients
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Hematology"
DOI: 10.1002/ajh.25359
Abstract: and Cor Pulmonale during severe acute chest syndrome in sickle cell disease. Am J Resp Crit Care Med. 2008;177(6):646-653. 7. Hambley BC, Rahman RA, O'Riordan MA, et al. Right-to-left shunts are unexpectedly common in adults… read more here.
Keywords: outcomes surgical; jehovah witness; anemia outcomes; surgical jehovah ... See more keywords
An evaluation of roxadustat for the treatment of anemia associated with chronic kidney disease.
Sign Up to like & getrecommendations! Published in 2021 at "Expert opinion on pharmacotherapy"
DOI: 10.1080/14656566.2021.1993821
Abstract: INTRODUCTION Anemia is one of the major complications of chronic kidney disease (CKD) and is associated with poor clinical outcomes. Erythropoiesis-stimulating agents (ESAs) have been the mainstay of renal anemia treatment. However, there are several… read more here.
Keywords: anemia; chronic kidney; treatment; treatment anemia ... See more keywords
The Use of Darbepoetin to Stimulate Erythropoiesis in the Treatment of Anemia of Chronic Kidney Disease in Dogs
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Veterinary Internal Medicine"
DOI: 10.1111/jvim.14681
Abstract: Background Darbepoetin alfa (darbepoetin) is an erythropoiesis‐stimulating agent used for the treatment of anemia secondary to chronic kidney disease (CKD) in dogs, but reports describing response are lacking. Hypothesis/Objectives To evaluate the effectiveness of darbepoetin… read more here.
Keywords: chronic kidney; treatment; treatment anemia; darbepoetin ... See more keywords
A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naïve Chronic Kidney Disease Patients Not on Dialysis
Sign Up to like & getrecommendations! Published in 2020 at "Nephron"
DOI: 10.1159/000508100
Abstract: Introduction: Roxadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor approved for the treatment of anemia in Japan for patients with dialysis-dependent (DD) chronic kidney disease (CKD). Objective: Multicenter, randomized, open-label, noncomparative, phase 3 study… read more here.
Keywords: treatment; study; treatment anemia; rate ... See more keywords
1455-P: Effect of Treatment of Anemia on HbA1c Levels
Sign Up to like & getrecommendations! Published in 2020 at "Diabetes"
DOI: 10.2337/db20-1455-p
Abstract: Introduction: While glucose remains the major determining factor of HbA1C, other conditions like hemolytic anemia, iron/vitamin B 12 deficiency anemia have also been shown to affect HbA1C. Material and Methods: A prospective study was carried… read more here.
Keywords: anemia; hba1c levels; hba1c; treatment anemia ... See more keywords
Altered Subpopulations of Red Blood Cells and Post-treatment Anemia in Malaria
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Physiology"
DOI: 10.3389/fphys.2022.875189
Abstract: In acute malaria, the bulk of erythrocyte loss occurs after therapy, with a nadir of hemoglobin generally observed 3–7 days after treatment. The fine mechanisms leading to this early post-treatment anemia are still elusive. We… read more here.
Keywords: rbc; treatment anemia; post treatment; treatment ... See more keywords